Member Benefit Category
Page Type
Member Benefits Page
Aspire has introduced a licensed version of Bisoprolol 1mg/ml oral solution (sugar-free). At the same time, an unlicensed version of Bisoprolol 5mg oral solution was listed in Part VIII B of the Drug Tariff.
Since a UK-licensed product became available in August, the Department of Health and Social Care (DHSC) has updated the payment arrangements for prescriptions claimed during August 2025. Here’s what you need to know:
| Prescribed product | Endorsed as | Reimbursement for prescriptions dispensed in August 2025 | |
| Bisoprolol 5mg/5ml oral solution | Aspire Pharma Ltd | Reimbursement based on the UK list price of Aspire Pharma Ltd product | |
Bisoprolol 5mg/5ml oral solution or Bisoprolol 5mg/5ml oral solution sugar free | Endorsed as a Part VIIIB special | Reimbursement based on August Drug Tariff Part VIIIB price | |
| Bisoprolol 5mg/5ml oral solution (Drug Tariff Special Order) | Endorsed as a Part VIIIB special | Reimbursement based on August Drug Tariff Part VIIIB price. | |
| Bisoprolol 5mg/5ml oral solution (Drug Tariff Special Order) | Aspire Pharma Ltd | Reimbursement based on August Drug Tariff Part VIIIB price. | |
| Bisoprolol 5mg/5ml oral solution sugar free (Drug Tariff Special Order) | Endorsed as a Part VIIIB special | Reimbursement based on August Drug Tariff Part VIIIB price | |
Bisoprolol 1mg/ml oral solution sugar free or Bisoprolol 1mg/ml oral solution sugar free (Aspire Pharma Ltd) | Aspire Pharma Ltd | Reimbursement based on the UK list price of Aspire Pharma Ltd product | |
Bisoprolol 1mg/ml oral solution or Bisoprolol 1mg/ml oral solution sugar free | No endorsement present | NHSBSA will contact the pharmacy to establish what was supplied and reimburse accordingly. | |
- The adjustment will automatically be applied for August which contractors will see in their relevant payments, Bisoprolol 5mg/5ml oral solution & Bisoprolol 5mg/5ml oral suspension have since been removed from September 2025 Tariff
- If you have any questions about the Drug Tariff - Call Information Services on 0800 783 5709 option 2